Dr Reddy's expects new GST framework to address critical issues impacting pharma sector

Dr Reddy's Laboratories anticipates that the new Goods and Services Tax structure will address existing challenges. It will also create a rationalised tax framework for the pharmaceutical sector. The Association of Indian Medical Device Industry seeks to retain 12 percent GST for most consumables. It also wants 5 percent rate on costly equipment.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/LN2v7zg
via IFTTT